The distribution of the Aspergillus fungus is currently shifting in notable ways. Studies reveal a clear northward movement of these airborne pathogens into areas that were once too chilly for them to thrive. This migration means a greater concentration of infectious spores is now found in heavily populated regions of Northern Europe and North America.
It’s not just a random occurrence; it stems from rising average temperatures. As habitats in the Southern Hemisphere become unsuitable due to heat, these fungi are adapting to new niches. This change is subtle, often happening in the soil and air without notice, until the fungus appears in clinical environments.
One major public health concern revolves around environmental resistance. Aspergillus faces the same antifungal chemicals in nature that are used in human treatments. This overlap leads to a sort of natural selection, allowing only the strongest strains to survive and potentially infect those with weakened health.
A multi-institutional study spearheaded by the University of Manchester aims to document this trend through 2025. On May 2025, the research team shared geospatial information showing that climate-related migration of Aspergillus is now exposing an additional 9 million people in Europe to these spores. Their findings, detailed in a preprint on Research Square, employ soil metabarcoding to trace the pathogen across the continent.
A Continent Under Spore Pressure
The research focuses on three primary species: Aspergillus fumigatus, Aspergillus flavus, and Aspergillus niger. Under high-emission climate scenarios, projections suggest that the range of A. fumigatus could grow by 77.5 percent throughout Europe. Globally, about 1.98 billion people live in environments conducive to this fungus, which is a significant cause of invasive aspergillosis, a life-threatening condition for immunocompromised individuals.
The study indicates that these pathogens are being pushed from their tropical origins due to rising temperatures, concentrating spores in northern regions. Places like Scandinavia and Alaska are emerging as new hotspots, while parts of Africa and South America become increasingly inhospitable for A. flavus, which now expands into Russia and northern China.
Collaboration on this research involved the Liverpool School of Tropical Medicine and the UK Centre for Ecology & Hydrology, with financial backing from the Wellcome Trust. The modeling uses the SSP585 warming scenario, which assumes continued heavy reliance on fossil fuels for decades to come.
This framework predicts a 16 percent increase in suitable habitats for A. flavus in Europe, meaning an additional one million people will now find themselves at risk of exposure. Currently, 905 million people are in areas that can support A. niger, while 846 million are in zones for A. flavus.
From Farm Furrows to Hospital Wards
The shift in fungal habitats also has direct consequences for global food systems. Aspergillus species often infect maize and rice crops, ruining yields and introducing harmful aflatoxins into the food chain. In the U.S., this contamination leads to annual losses up to $1 billion for the corn industry.
The overlap between agricultural environments and urban areas means that farmers use azole-based fungicides to safeguard their crops. However, medical professionals also use similar azole compounds to treat human infections, allowing the fungus to develop cross-resistance to antifungals.
Dr. Norman van Rhijn, who managed the mapping project at the University of Manchester, mentioned that “changes in factors like humidity and extreme weather will alter habitats and encourage fungal spread.” He pointed out that fungi are relatively overlooked in research compared to viruses and parasites, even as their global presence expands.
Viv Goosens, the Research Manager at Wellcome, reviewed the data, stating that “fungal pathogens are a serious threat to human health and can disrupt food systems. Climate change will likely exacerbate these risks.”
Mapping the Microscopic Threat
The predictive framework relies on global DNA sequencing data from soil samples. The team used a Maximum Entropy algorithm to analyze this data. They integrated environmental datasets with a human population database at a 1-kilometer resolution along with the CROPGRIDS global crop distribution index.
This model focuses on temperature, precipitation, and land-use metrics, establishing suitable habitat thresholds through the Maximum Test Sensitivity Plus Specificity method. Researchers confirmed the model’s accuracy through Receiver Operating Characteristic curves.
Annual mean temperature emerged as the most critical factor for determining fungal habitat conditions. Aspergillus spores are just two to three micrometers in size, enabling them to evade respiratory defenses and reach the pulmonary alveoli. These spores often emerge from environmental reservoirs like agricultural compost heaps, which can exceed temperatures of 50 degrees Celsius.
Clinical incidence rates generally correlate with these distribution findings. In 14 national groups studied, countries with a higher environmental presence of a specific strain reported more clinical infections. This relationship indicates that environmental density contributes to hospital admissions.
The clinical response to these infections can be slow. Doctors have to utilize various diagnostic methods, including computed tomography scans and polymerase chain reaction tests, which take time. This lag can allow strains with antifungal resistance to spread among patients who are already vulnerable due to weakened immune systems or chronic lung issues.
The research does highlight some limitations regarding micro-climates. While broad warming trends push the fungi northward, localized events can create temporary corridors for infection. Hospitals have seen increases in Aspergillus loads after incidents like dust storms or renovations, but these occurrences might not be captured in the current predictive model.





